Alison O'Neill
2020
In 2020, Alison O'Neill earned a total compensation of $862.1K as Chief Medical Officer at Surface Oncology.
Compensation breakdown
| Non-Equity Incentive Plan | $218,400 |
|---|---|
| Option Awards | $100,450 |
| Salary | $390,000 |
| Stock Awards | $143,100 |
| Other | $10,113 |
| Total | $862,063 |
O'Neill received $390K in salary, accounting for 45% of the total pay in 2020.
O'Neill also received $218.4K in non-equity incentive plan, $100.5K in option awards, $143.1K in stock awards and $10.1K in other compensation.
Rankings
In 2020, Alison O'Neill's compensation ranked 9,208th out of 13,090 executives tracked by ExecPay. In other words, O'Neill earned more than 29.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,208 out of 13,090 | 30th |
Division Manufacturing | 3,934 out of 5,621 | 30th |
Major group Chemicals And Allied Products | 1,596 out of 2,254 | 29th |
Industry group Drugs | 1,395 out of 1,954 | 29th |
Industry Biological Products, Except Diagnostic Substances | 326 out of 411 | 21st |
Source: SEC filing on April 26, 2022.
O'Neill's colleagues
We found three more compensation records of executives who worked with Alison O'Neill at Surface Oncology in 2020.